Myriad Genetics Inc (MYGN)
19.47
+0.25
(+1.30%)
USD |
NASDAQ |
May 03, 16:00
19.46
-0.01
(-0.05%)
After-Hours: 20:00
Myriad Genetics Max Drawdown (5Y): 80.57% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 80.57% |
March 31, 2024 | 80.57% |
February 29, 2024 | 80.57% |
January 31, 2024 | 80.57% |
December 31, 2023 | 80.57% |
November 30, 2023 | 80.57% |
October 31, 2023 | 80.57% |
September 30, 2023 | 80.57% |
August 31, 2023 | 80.57% |
July 31, 2023 | 80.57% |
June 30, 2023 | 80.57% |
May 31, 2023 | 80.57% |
April 30, 2023 | 80.57% |
March 31, 2023 | 80.57% |
February 28, 2023 | 80.57% |
January 31, 2023 | 80.57% |
December 31, 2022 | 80.57% |
November 30, 2022 | 80.57% |
October 31, 2022 | 80.57% |
September 30, 2022 | 80.57% |
August 31, 2022 | 80.57% |
July 31, 2022 | 80.57% |
June 30, 2022 | 80.57% |
May 31, 2022 | 80.57% |
April 30, 2022 | 80.57% |
Date | Value |
---|---|
March 31, 2022 | 80.57% |
February 28, 2022 | 80.57% |
January 31, 2022 | 80.57% |
December 31, 2021 | 80.57% |
November 30, 2021 | 80.57% |
October 31, 2021 | 80.57% |
September 30, 2021 | 80.57% |
August 31, 2021 | 80.57% |
July 31, 2021 | 80.57% |
June 30, 2021 | 80.57% |
May 31, 2021 | 80.57% |
April 30, 2021 | 80.57% |
March 31, 2021 | 80.57% |
February 28, 2021 | 80.57% |
January 31, 2021 | 80.57% |
December 31, 2020 | 80.57% |
November 30, 2020 | 80.57% |
October 31, 2020 | 80.57% |
September 30, 2020 | 80.57% |
August 31, 2020 | 80.57% |
July 31, 2020 | 80.57% |
June 30, 2020 | 80.57% |
May 31, 2020 | 80.57% |
April 30, 2020 | 80.57% |
March 31, 2020 | 80.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
66.64%
Minimum
May 2019
80.57%
Maximum
Mar 2020
78.25%
Average
80.57%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Stryker Corp | 43.80% |
Perspective Therapeutics Inc | 91.70% |
Electromed Inc | 55.84% |
Xtant Medical Holdings Inc | 98.66% |
Asensus Surgical Inc | 99.68% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -33.02 |
Beta (5Y) | 1.965 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 61.96% |
Historical Sharpe Ratio (5Y) | -0.1794 |
Historical Sortino (5Y) | -0.3194 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.62% |